聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 26 分钟 7 秒 前

Akcea Therapeutics Appoints Louis St. L. O'Dea as Chief Medical Officer

周二, 01/19/2016 - 15:45
Appointment adds depth in clinical and regulatory leadership CAMBRIDGE, Mass., Jan. 19, 2016 -- (Healthcare Sales & Marketing Network) -- Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals (IONS) focused on developing and commercializing new tre...
Biopharmaceuticals, Cardiology, Personnel
Akcea Therapeutics, Ionis Pharmaceuticals, lipodystrophy

Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection

周二, 01/19/2016 - 15:42
LAKE FOREST, Ill., Jan. 19, 2016 -- (Healthcare Sales & Marketing Network) -- Akorn, Inc. (AKRX), a leading specialty generic pharmaceutical company, today announced that it has launched Buprenorphine and Naloxone Sublingual Tablets CIII in 2mg/0.5mg and 8...
Biopharmaceuticals, Generics, Product Launch
Akorn, Buprenorphine, Naloxone, Tobramycin

Johnson and Johnson Announces Actions To Strengthen Medical Devices Leadership Position In Evolving Healthcare Marketplace

周二, 01/19/2016 - 15:38
Restructuring Designed to Accelerate Pace of Innovation, Address Unmet Patient Needs and Drive Growth Identifies Projected, Annualized Pre-Tax Cost Savings of $800 Million to $1.0 Billion, with Majority Realized by the End of 2018 Expects to Take Ass...
Devices, Personnel
Johnson & Johnson, Workforce Reduction

HiberGene Closes First Tranche of Series B Financing

周二, 01/19/2016 - 15:31
€1.5 Million Raised from Private Investors DUBLIN--(Healthcare Sales & Marketing Network)--HiberGene Diagnostics, a company focused on the application of molecular technology to infectious disease testing, has raised a first tranche of €1.5 million as p...
Diagnostics, Venture Capital
HiberGene Diagnostics, Streptococcus, Clostridium difficile, Norovirus

Acorda to Acquire Biotie Therapies

周二, 01/19/2016 - 15:28
Obtains global rights to Phase 3 Parkinson’s disease treatment and additional clinical-stage assets Positions Acorda as a leader in Parkinson’s disease therapeutic development Cash transaction valued at $363 million Enters into agreements for $135...
Biopharmaceuticals, Neurology, Mergers & Acquisitions
Acorda Therapeutics, Biotie Therapies, AMPYRA, dalfampridine, Parkinson’s

Michael Martino Named President and Chief Executive Officer of HemaFlo Therapeutics

周一, 01/18/2016 - 20:12
Industry veteran brings operating expertise to development-stage company focused on delivering therapies for diseases caused by poor blood flow CARLSBAD, Calif., Jan. 18, 2016 -- (Healthcare Sales & Marketing Network) -- HemaFlo Therapeutics, Inc. anno...
Biopharmaceuticals, Personnel
HemaFlo Therapeutics, NephroFlow, Drag Reducing Polymers, Acute Kidney Injury

iCo Strategic Reorganization

周一, 01/18/2016 - 13:15
VANCOUVER , Jan. 18, 2016 (Healthcare Sales & Marketing Network) - iCo Therapeutics Inc. ("iCo" or "the Company") (ICO.V) (ICOTF), today announced that effective immediately, in an effort to preserve its asset base and maximize sharehol...
Biopharmaceuticals, Personnel
iCo Therapeutics, Oral Amphotericin B

LifeWatch Receives FDA Clearance for its Mobile Cardiac Telemetry 1-Lead Patch

周一, 01/18/2016 - 13:05
ZUG, Switzerland , Jan. 18, 2016 (Healthcare Sales & Marketing Network) - LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services to the digital health market, is pleased to a...
Devices, Monitoring, Cardiology, FDA
LifeWatch AG, LifeWatch Mobile, Cardiac Telemetry

BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union

周日, 01/17/2016 - 04:00
Biogen will manufacture and commercialize BENEPALI in the EU ZUG, Switzerland--(Healthcare Sales & Marketing Network)--The joint venture between Biogen (BIIB) and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for...
Biopharmaceuticals, Regulatory
Biogen, Samsung BioLogics, biosimilar, BENEPALI, Etanercept, arthritis

Novartis receives two new FDA approvals for Cosentyx(R) (secukinumab) to treat patients with ankylosing spondylitis and psoriatic arthritis

周六, 01/16/2016 - 04:00
Cosentyx is the first and only interleukin-17A (IL-17A) antagonist approved for adult patients with active ankylosing spondylitis (AS) and psoriatic arthritis (PsA) Approvals for both indications based on efficacy and safety outcomes shown across four P...
Biopharmaceuticals, FDA
Novartis, Cosentyx, secukinumab, psoriasis, ankylosing spondylitis, arthritis

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

周五, 01/15/2016 - 13:24
IRVINE, Calif., Jan. 15, 2016 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced U.S. Food and Dru...
Devices, Cardiology, FDA
Edwards Lifesciences, aortic stenosis, SAPIEN 3, transcatheter valve

Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg

周五, 01/15/2016 - 13:14
EMVERM Provides a New Option for Patients with Pinworm, Whipworm, Roundworm and Hookworm in Single or Mixed Infections HAYWARD, Calif., Jan. 15, 2016 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (IPXL) today announced that the ...
Biopharmaceuticals, FDA
Impax Laboratories, EMVERM, common roundworm, common hookworm

Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events

周四, 01/14/2016 - 17:02
MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today provided an update of key corporate initiatives which, if successful, will expand the utility and regulatory...
Devices, Cardiology
Hansen Medical, intravascular robotics, Magellan, Sensei

Imricor Medical Systems Receives CE Mark for MR Compatible Advantage-MR EP Recorder and Stimulator System

周四, 01/14/2016 - 16:58
MINNEAPOLIS, Jan. 14, 2016 -- (Healthcare Sales & Marketing Network) -- Imricor Medical Systems announced today that it has received CE mark for its Advantage-MR™ EP Recorder/Stimulator System; a first-of-its-kind MR Conditional recording system for MRI-g...
Devices, Cardiology, Regulatory
Imricor Medical Systems, MRI-guided electrophysiology

IsoRay Appoints Thomas LaVoy as CEO to Take Office on February 15

周四, 01/14/2016 - 16:55
RICHLAND, Wash., Jan. 14, 2016 -- (Healthcare Sales & Marketing Network) -- IsoRay Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head...
Devices, Oncology, Personnel
IsoRay, brachytherapy, radiotherapy

Hansen Medical Announces Exploration of Strategic Alternatives

周四, 01/14/2016 - 13:53
MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, announced today that its board of directors has entered a process to explore strategic alternatives for the compan...
Devices, Cardiology
Hansen Medical, intravascular robotics, Magellan Robotic

Avita Medical Appoints Distributors in Japan and South Korea

周四, 01/14/2016 - 13:46
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Healthcare Sales & Marketing Network) - Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specialising in new treatments for wounds and skin defects, announced...
Devices, Wound Care, Distribution
Avita Medical, ReCell , INDEE Medical, TRM Korea

Oculus Innovative Sciences Receives European CE Mark for New MucoClyns(TM) for First Responders

周四, 01/14/2016 - 13:40
PETALUMA, Calif., Jan. 14, 2016 -- (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (OCLS), warrants OCLSW, a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and ...
Biopharmaceuticals, Dermatology, Regulatory
Oculus Innovative Sciences, MucoClyns

Contego Medical Announces European Commercialization of the Paladin(R) Carotid Post-Dilation Balloon with Integrated Embolic Protection(TM) Technology

周四, 01/14/2016 - 13:33
Presenting at the Leipzig Interventional Course (LINC) from January 26th-29th in Leipzig, Germany. RALEIGH, N.C., Jan. 14, 2016 -- (Healthcare Sales & Marketing Network) -- Contego Medical today announced the European commercialization of the Paladin&r...
Devices, Interventional, Product Launch
Contego Medical, Paladin System, angioplasty balloon, Embolic Protection

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong